Satellos Bioscience MSLE
NASDAQ MSLE
$8.71 +0.23 (+2.77%)
As of: Oct 1, 2026 · 10:23 AM EDT

Satellos Bioscience (MSLE) Free Cash Flow (2026)

Updated

Satellos Bioscience's Free Cash Flow was $4,000 in the quarter ended Mar 31, 2026.

Analysis

Satellos Bioscience (MSLE) Free Cash Flow (2026) Analysis & Trends

For the year ended Dec 31, 2025, Free Cash Flow at Satellos Bioscience came in at -$23.59 million.

  • In earlier years, Free Cash Flow was -$18.25 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 7.30 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.11 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 4.48 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 6.20 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 5.34 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 3.49 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.43 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 302.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.01 Bn
10 Satellos Bioscience 131.40 Mn 131.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 4,000.00
API Access

Satellos Bioscience Free Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow&ticker=MSLE&period=max&api_key=YOUR_API_KEY